Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 251-259

  Trouplin, V ^a   Salvatori, F ^a   Cappello, F ^a   Obry, V ^a   Brelot, A ^a   Heveker, N ^a   Alizon, M ^a   Scarlatti, G ^a   Clavel, F ^a   Mammano, F ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TECHNIQUE; VIRUS CULTURE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; CELLS, CULTURED; GENETIC VECTORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINATION, GENETIC; VIREMIA; VIRUS REPLICATION;

EID: 0034749279     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.251-259.2001     Document Type: Article

References (80)

1. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for maerophage-tropic HIV-1
2. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation
3. HIV entry and tropism: The chemokine receptor connection
4. A new classification for HIV-1
5. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
6. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
7. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism
8. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells
9. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
10. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: Definition of critical amino acids involved in cell tropism
11. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
12. HIV and chemokines: Ligands sharing cell-surface receptors
13. HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands
14. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
15. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
16. Increased viral burden and cytopathicity, correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
17. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
18. Synctium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population
19. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution
20. Identification of a major co-receptor for primary isolates of HIV-1
21. Expression cloning of new receptors used by simian and human immunodeficiency viruses
22. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
23. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
24. A sensitive method for the detection of β-galactosidase in transfected mammalian cells
25. Changing the natural history of HIV disease
26. Confidence limits on phylogenies: An approach using the bootstrap
27. HIV-1 entry cofactor: Functional eDNA cloning of a seven-transmembrane, G proteincoupled receptor
28. Biological phenotypes of HIV-1 in pathogenesis and transmission
29. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
30. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
31. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
32. Relation of phenotype evolution of HIV-1 to envelope V2 configuration
33. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line
34. HIV-1 envelope determinants for cell tropism and chemokine receptor use
35. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1
36. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
37. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse
38. Predictors of rapid progression to AIDS in HIV-1 seroconverters
39. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
40. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS
41. Signature pattern analysis: A method for assessing viral sequence relatedness
42. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100
43. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1
44. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates
45. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
46. Importance of method in the determination of syncytium-inducing phenotype of human immunodeficiency virus type 1 clinical isolates
47. Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages
48. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug
49. Co-receptors for HIV-1 entry
50. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
51. Functional characterization of the V1V2 region of human immunodeficiency virus type 1
52. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy
53. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
54. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
55. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice
56. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes
57. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry
58. The impact of the syncytiuminducing phenotype of human immunodeficiency virus on disease progression
59. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
60. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease
61. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
62. Macrophage-tropic HIV-1 variants: Initiators of infection and AIDS pathogenesis?
63. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
64. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice
65. Macrophage and T-cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
66. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1
67. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
68. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
69. Host range mutant of human immunodeficiency virus type 1: Modification of cell tropism by a single point mutation at the neutralization epitope in the env gene
70. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection
71. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission
72. Viral dynamics in human immunodeficiency virus type 1 infection
73. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
74. Selectire transmission of human immunodeficiency virus type-1 variants from mothers to infants
75. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
76. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
77. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1
78. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
79. Genotypic and phenotypic characterization of HIV-1 patients with primary infection